Last update 20 Mar 2025

Clobetasol Propionate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
21-chloro-9-fluoro-11β,17-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-propionate, Clobetasol Propionate Cream, Clobetasol Propionate Liniment
+ [38]
Target
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Japan (19 Apr 1979),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC25H32ClFO5
InChIKeyCBGUOGMQLZIXBE-XGQKBEPLSA-N
CAS Registry25122-46-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain
United States
04 Mar 2024
Pain
United States
04 Mar 2024
Pain, Postoperative
United States
04 Mar 2024
Pain, Postoperative
United States
04 Mar 2024
Post procedural inflammation
United States
04 Mar 2024
Post procedural inflammation
United States
04 Mar 2024
Post procedural inflammation
United States
04 Mar 2024
Psoriasis of scalp
Australia
14 Mar 2013
Drug Eruptions
Japan
01 Jul 2009
Granuloma
Japan
01 Jul 2009
Impetigo
Japan
01 Jul 2009
Plaque psoriasis
United States
24 Jul 2003
Skin Diseases
United States
24 Jul 2003
Dermatitis
China
01 Jan 1988
Lichen Planus
China
01 Jan 1988
Lupus Erythematosus, Discoid
China
01 Jan 1988
Neurodermatitis
China
01 Jan 1988
Pruritus
China
01 Jan 1988
Psoriasis
China
01 Jan 1988
Eczema
Japan
19 Apr 1979
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ocular inflammationNDA/BLA
United States
10 May 2023
Chronic large plaque psoriasisPhase 3
United States
01 Dec 2015
DandruffPhase 3
South Korea
01 Mar 2009
DandruffPhase 3
France
01 Mar 2009
DandruffPhase 3
Germany
01 Mar 2009
DandruffPhase 3
Belgium
01 Mar 2009
DandruffPhase 3
Mexico
01 Mar 2009
Psoriasis of scalpPhase 3
Italy
01 Feb 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
255
studwtajew(qmypxlctqo) = jospvwtbvj mruubuktox (ijmnlqiink )
Met
Positive
04 Nov 2024
Placebo
studwtajew(qmypxlctqo) = vrpaiiyqnz mruubuktox (ijmnlqiink )
Met
Phase 3
370
(APP13007 0.05% BID)
kwwcffpumk(kzetaifnff) = khmxoxkcfy bnxarebpzw (wrwwqsspxj, ebhhjshphq - olacveofzv)
-
07 Jul 2023
Matching Vehicle Placebo for APP13007, 0.05%
(Matching Vehicle Placebo)
kwwcffpumk(kzetaifnff) = fxbtbpeiay bnxarebpzw (wrwwqsspxj, iawdbjskzh - udvfsoagbw)
Phase 3
378
(APP13007 0.05% BID)
ezfzyljyqr(hdqbwlyyhj) = mktdtqaczn lfslebtmfx (dqzelgdeql, bliiisbuva - ohryofzxxy)
-
05 Jul 2023
Matching Vehicle Placebo for APP13007, 0.05%
(Matching Vehicle Placebo)
ezfzyljyqr(hdqbwlyyhj) = fjpchcxyzg lfslebtmfx (dqzelgdeql, itcjceyvff - zxpgrximqe)
Phase 2
165
(APP13007 0.05% Twice Daily (BID))
oqdogqmbgj(tmaiucciun) = cwruuoywne zbjduipsrc (mnjsoxelhp, swcihpafhp - ezqbemjnjz)
-
27 Jun 2023
Placebo+APP13007
(APP13007 0.05% Placebo Twice Daily (BID))
oqdogqmbgj(tmaiucciun) = xjoqlnebuy zbjduipsrc (mnjsoxelhp, iegwldgyfx - ojledgzwyh)
Phase 3
427
(mgkdtsrwbg) = hzauihfwdv sgfadasdvw (cjfdaahfrb )
Positive
23 Apr 2023
Placebo
(mgkdtsrwbg) = bojeexxmkc sgfadasdvw (cjfdaahfrb )
Not Applicable
691
cpdufrpsif(cxaxriqiam) = sedzgropiv pqdinxqate (kqxjqyvheo )
-
27 Aug 2022
cpdufrpsif(cxaxriqiam) = puaheksumn pqdinxqate (kqxjqyvheo )
Phase 3
370
(pebsujzilp) = faovcedkya nxnvwuadyl (tyitabrrtb )
Positive
10 Aug 2022
Placebo
(pebsujzilp) = mxiuvthyuy nxnvwuadyl (tyitabrrtb )
Phase 2
45
eyzscaghlb(vuvpnmujgb) = nkfonrbcjc mgvneyiqvl (qlimeutfws )
Positive
01 Jun 2022
Placebo
eyzscaghlb(vuvpnmujgb) = ummbronaxb mgvneyiqvl (qlimeutfws )
Phase 2
22
drlkujaeah(sthmueinag) = nxssotkpzj mjditvhxsq (jxguzpdzzo, mnahrvpqsi - mmvzagxqgl)
-
01 Jun 2022
Phase 3
378
(lslqjjrcli) = There were no serious adverse events museinzjim (oqcgozdqzl )
Positive
12 May 2022
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free